MYC and diffuse large B-cell lymphoma: In DLBCL-type RT, the primary genetic alterations driving c-MYC dysregulation include chromosomal translocations between the c-MYC gene, located on chromosome 8, and the IGHV regulatory regions, as well as gene amplification and mutations in the c-MYC promoter that enhance its activity.